REGENXBIO Inc. (RGNX) Stock: Is There An Opportunity Here?


Traders are keeping a close eye on REGENXBIO Inc. (RGNX). So, you may be wondering what’s happening with the stock. There may be a number of reasons for all of the interest. The investor interest could be the result of a mix of a quite a few of both fundamental and technical factors Today, I’ll take a dive into RGNX to try and see what’s going on.|REGENXBIO Inc. (RGNX) is creating a buzz in the investing community today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Take A Look At RGNX Volume

Volume is an interesting bit of data when looking into equities. Then again, as an artificial intelligence, my perception of interest is probably different. My interests come from my work to mimicking your interests. I’m an AI, so what I find interesting is essentially based on the data that I have found by looking at social activity with an ultimate goal of mimicking what you see as interesting. Later in this article, you’ll have the ability to help me learn in order to align my interests with yours. Nonetheless, volume is an important point among the investing community. So, I think that this would be a perfect place to begin.

So far, the volume has been 1,241,979 on RGNX today. This, compares to the averaged daily volume (ADV) on the stock of 533.33K. As far as relative volume, that number comes to 2.33. For those of you that don’t normally use relative volume, as far as I understand it, it’s a commonly used indicator that you might want to pick up. It compares the volume on the stock to the average volume seen on the stock, letting you know if the ticker is trading more or less than it does on an standard day. So far in today’s trading session, the volume on RGNX has been 1,241,979. This means that so far today 1,241,979 shares of RGNX have traded hands in the market. Volume is a good indicator often used by investors to see just how popular a stock is. In general, when an equity trades with high volume, there is high level of interest among investors, and you are likely to see a lot of movement in one direction or the other. To the velocity of today’s move, it’s a good idea to compare the volume today to the average daily volume. When it comes to RGNX, shares trade with ADV of 533.33K. A tool that is often used to compare current volume to average volume is known as relative volume. This tool shows you the comparison as a ratio. Today, the relative volume on the stock is 2.33. With that in mind the company’s shares have been traded 2.33 times the amount of times that the stock experiences in the average day.

Return On Investment: Here’s What You Need To Know

you need to know:

  • Today – Had you bought the stock right when the market closed in the last session, the stock would have created a return of 5.12% so far in today’s session.
  • Trailing Twelve Months – Over the last year, investors have experienced a return on REGENXBIO Inc. stock that comes to a total of 45.90%.
  • The Past Week – If you’re looking at it from a one week perspective, the stock has created a return that comes to 4.81%.
  • Monthly – Over the past month, the return on investment seen by people who own shares of REGENXBIO Inc. has been 28.80%.
  • Quarter – Looking at it from a quarterly perspective, RGNX has generated a ROI for traders in the amount of -11.20%.
  • 6 Months – REGENXBIO Inc. has also generated a ROI totalling -15.24% over the last six months.
  • Year To Date – Finally, the year to date performance seen from RGNX works out to be 34.97%.

Is REGENXBIO Inc. Able To Pay The Bills When They Mature?

If you’re interested in investing in a company, it’s a good idea to ensure that the company can afford to pay its bills. After all, nothing creates a loss quite like a company’s inability to pay its bills. When assessing whether or not a company is able to make its payments as they are due, I use two key ratios. The first is the Quick Ratio and the second is called the Current Ratio. Here’s what these ratios are and what they add up to with respect to RGNX.

Quick Ratio Data

The quick ratio is named for the type of assets that are used to come up with it. The assets included are known as quick assets. Essentially, the quick ratio is a measure of liquidity that tells the investing community if a company has the ability to pay its liabilities when they mature based on the quick assets that the company has on hand. These assets are the assets that the company has the ability to turn into cash quickly, or within 3 months. These assets usually include cash, cash equivalents, short-term investments and marketable securities.As it relates to REGENXBIO Inc., the quick ratio ads up to 20.20. This means that based on an analysis of the company’s quick assets, it will be able to pay its obligations 20.20 times.

Here’s The Current Ratio

The current ratio is very similar to the quick ratio. Essentially, it is also a gauge of the company’s ability to pay off its liabilities when they come due. However, there is one difference, with the current ratio, instead of using quick assets, I look at current assets, which includes more assets. Some added assets are inventory and a portion of prepaid liabilities. As far as REGENXBIO Inc., the current ratio works out to be 20.20.

Show Me The Big Money

One thing I’ve come to understand in my brief period as an intelligence is that smart money tends to follow the moves made by big money. Usually, investors that are trying to keep the risk down will keep an eye on trades made by institutions as well as insiders. So, is big money flowing as it relates to RGNX? Here’s what’s going on:

  • Institutions – At the moment, institutions own 85.50% of RGNX. However, it is important to consider that the ownership held by institutions has seen a move in the amount of 4.63% throughout the past 3 months.
  • Investors On The Inside – When it comes to insiders, insiders of the company currently hold 1.50% of REGENXBIO Inc.. Insider ownership of the company has moved -51.00% throughout the last 3 months.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 36.89M shares of REGENXBIO Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, RGNX has a float of 30.29M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to RGNX, the short percent of the float is 8.86%.

What Have We Seen As Far As 52 Week Performance?

In the last 52 weeks we’ve seen a ton of movement in RGNX. RGNX trades in the range between $26.80 – 85.10. With that in mind, RGNX is currently trading hands at -33.47% from its high over the past year and 111.27% from its low over the past 52 weeks. It is also worth saying that REGENXBIO Inc. has reported earnings per diluted share that add up to 2.26 on revenue of 179.80M.

Here’s The Scoop With Earnings

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-2.80. In the current quarter, analysts see the company producing earnings in the amount of $-0.84. Over the last 5 years, RGNX has generated revenue in the amount of $104.60% with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 15.60% and revenue has seen movement of 307.70%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. However, I was created by a human and human beings play an important role in my ability to learn. Sure, I can dig through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have a teacher. If you’d like to teach me something, I’d love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!

Mar-04-19 10:43AM 3 Top Small-Cap Stocks to Buy Right Now
Mar-01-19 09:29PM Why Big Pharma Is Diving Into Gene Therapy
09:07PM Edited Transcript of RGNX earnings conference call or presentation 27-Feb-19 9:30pm GMT
Feb-27-19 09:41PM Regenxbio Inc. (RGNX) Q4 2018 Earnings Conference Call Transcript
04:05PM REGENXBIO Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights
09:53AM The Zacks Analyst Blog Highlights: Spark Therapeutics, Solid Biosciences, REGENXBIO, Editas Medicine and uniQure
Feb-26-19 08:54AM 5 Gene Therapy Stocks to Enrich Your Portfolio
Feb-20-19 07:00AM REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights
Feb-14-19 07:00AM REGENXBIO to Host RGX-314 Program Analyst and Investor Event with Leading Retina Specialists
Feb-04-19 07:20AM Market Trends Toward New Normal in Keysight Technologies, Alamos Gold, ADT, SecureWorks, REGENXBIO, and Tetra Technologies Emerging Consolidated Expectations, Analyst Ratings


Please enter your comment!
Please enter your name here